Inventiva (IVA) Research & Development (2019 - 2021)
Inventiva (IVA) recorded quarterly Research & Development of -$14.3 million in Q2 2021, down 65.27% quarter-over-quarter from -$8.7 million in Q1 2021, and down 99.91% on a YoY basis from -$15.3 billion in Q2 2020.
Inventiva (IVA) Research & Development (2019 - 2021) Analysis & Trends
Inventiva's Research & Development history runs 3 years deep, the most recent figure standing at -$14.3 million for Q2 2021.
- In Q2 2021, Research & Development fell 99.91% year-over-year to -$14.3 million; the TTM figure through Jun 2021 stood at -$58.5 million (changed N/A YoY), while the FY2025 annual figure was $101.3 million, up 4.33% from the prior year.
- Research & Development was -$14.3 million for Q2 2021 at Inventiva, down from -$8.7 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of -$6.7 million in Q1 2020 to a low of -$37.4 million in Q4 2019.
- Historically, Research & Development has averaged -$17.1 million across 3 years, with a median of -$11.5 million in 2021.
- The sharpest annual moves came in 2020 and 2021: Research & Development rose 24.4% in 2020, then plunged 99.91% in 2021.
- A 3-year view of Research & Development shows it stood at -$37.4 million in 2019, then advanced by 24.4% to -$28.3 million in 2020, then soared by 49.27% to -$14.3 million in 2021.
- The last three Research & Development figures came in at -$14.3 million (Q2 2021), -$8.7 million (Q1 2021), and -$28.3 million (Q4 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 1.46 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -2.30 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -58.00 Mn |
| 10 | Inventiva | 8.78 Mn | -259.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -14.35 Mn |
| Mar 31, 2021 | -8.68 Mn |
| Dec 31, 2020 | -28.28 Mn |
| Jun 30, 2020 | -7.18 Mn |
| Mar 31, 2020 | -6.69 Mn |
| Dec 31, 2019 | -37.40 Mn |